Woodline Partners’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.79M Hold
2,105,486
– – 0.01% 788
2026
Q2
$4.72M Buy
+2,105,486
New +$3.96M 0.01% 702
2025
Q3
– Sell
-751,267
Closed -$594K – 968
2025
Q2
$594K Buy
751,267
+283
+0% +$335 ﹤0.01% 842
2025
Q1
$766K Buy
+750,984
New +$1.42M 0.01% 788
2024
Q3
– Sell
-173,586
Closed -$302K – 652
2024
Q2
$302K Buy
+173,586
New +$255K ﹤0.01% 520
2023
Q4
– Sell
-130,293
Closed -$388K – 562
2023
Q3
$388K Sell
130,293
-362,303
-74% -$1.38M ﹤0.01% 517
2023
Q2
$2.2M Buy
+492,596
New +$2.21M 0.03% 415

Other funds holding IFRX

Woodline Partners's IFRX Position: Q3 2026 in Review

Woodline Partners held its InflaRx (IFRX) position steady in Q3 2026 at 2,105,486 shares worth $3.79M. The position accounts for 0.01% of the portfolio, ranked #788.

Woodline Partners first reported a position in IFRX in Q2 2023 and has held it in 7 quarters since. The position peaked at $4.72M in Q2 2026. 64 funds tracked by Wall St. Rank hold IFRX as of Q3 2026.

  • Woodline Partners held 2,105,486 shares of InflaRx worth $3.79M as of Q3 2026.
  • Woodline Partners left its InflaRx share count unchanged in Q3 2026.
  • InflaRx made up 0.01% of Woodline Partners's portfolio in Q3 2026, its #788 holding.
  • Woodline Partners first reported a position in InflaRx in Q2 2023 and has held it in 7 quarters since.
  • Woodline Partners's InflaRx position peaked at $4.72M in Q2 2026.
  • 64 funds tracked by Wall St. Rank held InflaRx as of Q3 2026.

Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.